What stage does Nimbus Synergies Inc. invest at?

Nimbus Synergies Inc. invests at the Pre-Seed, Seed, Series A stages.

What is Nimbus Synergies Inc.'s typical check size?

Nimbus Synergies Inc. typically writes checks of $250K – $2M.

What sectors does Nimbus Synergies Inc. focus on?

Nimbus Synergies Inc. focuses on Biotech, Digital Health, Healthtech, Medical Devices, Sector Agnostic.

Where is Nimbus Synergies Inc. located?

Nimbus Synergies Inc. is headquartered in Vancouver, CA.

Does Nimbus Synergies Inc. lead rounds?

Yes, Nimbus Synergies Inc. leads investment rounds.

Nimbus Synergies Inc.

Venture capital

Vancouver · Pre-Seed–Series A · 16 people tracked

★ Follow + Add to CRM ⤳ Find an introduction

Find your way into Nimbus Synergies Inc.

1,769 people in our graph share verified history with the Nimbus Synergies Inc. team — schools, employers, funds. One of them is your warm intro.

Harley Finkelsteinunlockedknows Jason Robertson · together at McGill University (overlapped)

×2knows the team · via University of California, Berkeley, Haas School of Business

×3knows the team · via University of Cambridge

×2knows the team · via Creative Destruction Lab

×2knows the team · via Evercore

knows the team · via Permira

✨ Fox Verdict

Investment thesis

Nimbus focuses on the future of healthcare, backing early-stage companies that leverage technology to transform how care is accessed and delivered. The firm targets ventures aiming to improve patient outcomes, boost efficiency, and reduce costs while driving system-wide improvements across healthcare delivery.

Invests inBiotech Digital Health Healthtech Medical DevicesSector AgnosticCanada North America Vancouver

Source: firm website, verified Aug 3, 2026.

Stage

Pre-Seed–Series A

Check

$250K – $2M

Vancouver, British Columbia, CA

Leads rounds

Leads

Instruments

Equity

Founded

2017

AUM

$30M

Tracked investments

Team · 16 people

from the firm's website & curated & public directories

Jason Robertson· Managing Partner· Vancouver, BCin 𝕏

Jason Robertson is CEO, Managing Partner, and Co-Founder of Nimbus Synergies, a $35M evergreen seed fund investing $250K–$1M in early-stage health tech companies across digital health, health IT, and medtech, with a portfolio of 14 companies. Previously, he held the position of Head of Business Development at Aquinox Pharmaceuticals, where he contributed to raising over $200M and facilitation of a NASDAQ IPO and $155M partnership with Astellas Pharma. Robertson holds a B.Sc. in Microbiology & Immunology from McGill University and an MBA in Finance and Strategy from UBC, and serves as Board Director at LifeBooster, Claris Healthcare, Clarius Mobile, Sonic Incytes, and Variational AI, while also operating The GENERATOR, a health tech hub that has supported over 80 companies since its inception.

j•••@nimbusinc.vcreveal

Ari Gupta· Community Manager

Bree Stanlake· Director

Mathew Merrit· CFO· Greater Vancouver Metropolitan Areain

Michael Ball· Director

Morgan Sturdy· Board Chair / Director

Nancy Harrison· Director

Nidhi Kamal Mohan· Investment Associate

Wendy Hurlburt· Director

Laura Cassin· Associate· Vancouver, BCin 𝕏

l•••@nimbusinc.vcreveal

Mathew Merritt· CFO· Greater Vancouver Metropolitan Areain

m•••@nimbusinc.vcreveal

Paul Geyer· Director

p•••@nimbusinc.vcreveal

Vivian Wang· Investment Associate

v•••@nimbusinc.vcreveal

Alexander Bell· CFO· United Kingdomin

Michael Fair· CFO· Chapel Hill, North Carolinain

Joined in 2019, responsible for analysis, research, diligence, and business development; previously worked at Duff & Phelps and Houlihan Lokey on illiquid investment valuations.

m•••@morgancreekcap.comreveal

Nancy Harrison· Board Member· Vancouver, BCin

Venture Partner who joined Amplitude in 2020, with over 30 years in life sciences and both company-creation and VC experience, previously a Partner at Ventures West and co-founder/president of MSI Methylation Sciences.

n•••@amplitudevc.comreveal

What they invest in

from 4 of 4 portfolio companies

AI & Machine Learning ×2Healthtech ×2Biotech ×1Deep Tech ×1Digital Health ×1Direct to Consumer ×1Enterprise Software ×1Medical Devices ×1

HQs:Canada×3

Investments · 4 tracked

founders shown can be your intro path

Variationalvariational.ai in✓ verified

Variational AI develops generative AI technology to accelerate small molecule drug discovery for pharmaceutical partners.

AI & Machine LearningBiotechDeep Tech

Handol Kim(Co-Founder & CEO)Jason Rolfe(Co-Founder & CTO)Ali Saberali(Co-Founder & Head of Platform)

Co-investorsFlying Fish Ventures Merck Global Health Innovation Fund

EmergConnectemergconnect.ca inMar 2025

EmergConnect automates patient intake, triage, and communication in emergency departments to reduce wait times and administrative workload.

Enterprise SoftwareHealthtechSaaS

Ron Galaev in

Co-investorsFront Row Ventures Anges Québec AQC Capital Capital Angel Network Leva Capital Maple Leaf Angels

Sonic Incytessonicincytes.com in 𝕏

Sonic Incytes Medical Corp. develops Velacur ONE, an AI-guided ultrasound system that provides quantitative liver stiffness and attenuation measurements at the point of care.

AI & Machine LearningDigital HealthMedical DevicesVancouver, CA

Julio Lobo(VP, Research & Development (founding team member))inBarry Allen(President & Chief Executive Officer)in Paolo Jelmoni(Chief Commercial Officer)in Richard Rawnsley(Chief Financial Officer)in

Co-investorsConvergent Ventures Flucas Ventures Wavemaker Three-Sixty Health

Vitamin-One Formulas Ltd.getvitaminlab.com 𝕏

VitaminLab creates personalized supplement formulations tailored to individual health data, goals, and lifestyle needs.

Direct to ConsumerHealthtechWellness & FitnessBritish Columbia, CA

Anton

Co-investorsAngel Forum Relentless Pursuit Partners Sproutx WUTIF Capital

Portfolio news

latest coverage across their companies

Patients - EmergConnect

EmergConnect · emergconnect.com · Sep 26, 2025

FDA clears Sonic Incytes’ POCUS device | AuntMinnie

Sonic Incytes · auntminnie.com · Aug 13, 2025

Frequently asked questions

What stage does Nimbus Synergies Inc. invest at?: Nimbus Synergies Inc. invests at the Pre-Seed, Seed, Series A stages.
What is Nimbus Synergies Inc.'s typical check size?: Nimbus Synergies Inc. typically writes checks of $250K – $2M.
What sectors does Nimbus Synergies Inc. focus on?: Nimbus Synergies Inc. focuses on Biotech, Digital Health, Healthtech, Medical Devices, Sector Agnostic.
Where is Nimbus Synergies Inc. located?: Nimbus Synergies Inc. is headquartered in Vancouver, CA.
Does Nimbus Synergies Inc. lead rounds?: Yes, Nimbus Synergies Inc. leads investment rounds.

Similar investors

Kleiner Perkins

Kleiner Perkins is a venture capital firm that backs founders across technology and life sciences, from early stage through growth.

$500K – $15M

Overwater Ventures Llc

Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.

$400K – $2M

Alumni Ventures

Alumni Ventures (AV) is a venture capital firm that co-invests alongside lead VCs in startups, backing founders with capital and access to a large investor and operator community.

$100K – $10M

Qbic Fund

Qbic is an inter-university venture capital fund that turns technological breakthroughs from its partner universities, research institutes and hospitals into sustainable businesses.

Villgro Africa

Villgro Africa is an incubator and impact investor that supports early-stage healthcare and life science startups across Africa, offering personalised incubation to help them scale.